The impact of community-based non-pharmacological interventions on cardiovascular and kidney disease outcomes in remote dwelling Indigenous communities: A scoping review protocol.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2022
Historique:
received: 31 08 2021
accepted: 27 05 2022
entrez: 10 6 2022
pubmed: 11 6 2022
medline: 15 6 2022
Statut: epublish

Résumé

Indigenous people represent approximately 5% of the world's population. However, they often have a disproportionately higher burden of cardiovascular disease (CVD) risk and chronic kidney disease (CKD) than their equivalent general population. Several non-pharmacological interventions (e.g., educational) have been used to reduce CVD and kidney disease risk factors in Indigenous groups. The aim of this paper is to describe the protocol for a scoping review that will assess the impact of non-pharmacological interventions carried out in Indigenous and remote dwelling populations to reduce CVD risk factors and CKD. This scoping review will be guided by the methodological framework for conducting scoping studies developed by Arksey and O'Malley. Both empirical (Medline, Embase, Cochrane Library, CINAHL, ISI Web of Science and PsycINFO) and grey literature references will be assessed if they focused on interventions targeted at reducing CVD or CKD among Indigenous groups. Two reviewers will independently screen references in consecutive stages of title/abstract screening and then full-text screening. Impact of interventions used will be assessed using the reach, effectiveness, adoption, implementation, maintenance (RE-AIM) framework. A descriptive overview, tabular summaries, and content analysis will be carried out on the extracted data. This review will collect and analyse evidence on the impact of interventions of research carried out to reduce CVD and CKD among Indigenous populations. Such evidence will be disseminated using traditional approaches that includes open-access peer-reviewed publication, scientific presentations, and a report. Also, we will disseminate our findings to the government and Indigenous leaders. Ethical approval will not be required for this scoping review as the data used will be extracted from already published studies with publicly accessible data.

Identifiants

pubmed: 35687551
doi: 10.1371/journal.pone.0269839
pii: PONE-D-21-28289
pmc: PMC9187124
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0269839

Subventions

Organisme : CIHR
ID : RES0046966
Pays : Canada

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

J Health Care Poor Underserved. 2019;30(2):618-636
pubmed: 31130541
Lancet. 2020 Oct 17;396(10258):1223-1249
pubmed: 33069327
Am J Prev Med. 2006 Jan;30(1):67-73
pubmed: 16414426
BMC Health Serv Res. 2019 Dec 19;19(1):978
pubmed: 31856808
Diabetes Res Clin Pract. 2018 Apr;138:271-281
pubmed: 29496507
Am J Public Health. 1999 Sep;89(9):1322-7
pubmed: 10474547
Nephrol Dial Transplant. 2010 Oct;25(10):3260-6
pubmed: 20375028
Aust J Rural Health. 2015 Dec;23(6):318-21
pubmed: 26683713
SAGE Open Med. 2020 Nov 20;8:2050312120973842
pubmed: 33282301
Med Decis Making. 2020 Apr;40(3):289-301
pubmed: 32428430
Implement Sci. 2019 Aug 14;14(1):81
pubmed: 31412894
JBI Evid Synth. 2020 Oct;18(10):2119-2126
pubmed: 33038124
Lancet. 2015 Aug 22;386(9995):743-800
pubmed: 26063472
Can J Kidney Health Dis. 2019 Nov 14;6:2054358119887154
pubmed: 31798926
Lancet. 2015 Mar 14;385(9972):966-76
pubmed: 25784347
Nurs Health Sci. 2015 Sep;17(3):362-9
pubmed: 25818472
Lancet Planet Health. 2019 Dec;3(12):e511-e520
pubmed: 31868600
CMAJ. 2013 Jun 11;185(9):E417-23
pubmed: 23649413
Mhealth. 2020 Oct 05;6:40
pubmed: 33437836
BMC Nephrol. 2020 Nov 19;21(1):497
pubmed: 33213413
Int J Equity Health. 2018 Sep 27;17(1):153
pubmed: 30261878
Med J Aust. 2000 May 15;172(10):473-8
pubmed: 10901769
J Clin Epidemiol. 2014 Dec;67(12):1291-4
pubmed: 25034198
Diabetes Res Clin Pract. 2008 Oct;82(1):1-17
pubmed: 18768236
J Clin Lipidol. 2010 Sep-Oct;4(5):435-43
pubmed: 21076630
BMC Med Res Methodol. 2013 Mar 23;13:48
pubmed: 23522333
Aust N Z J Public Health. 2017 Oct;41(5):460-466
pubmed: 27372907
PLoS One. 2016 Jul 06;11(7):e0158765
pubmed: 27383068
SAGE Open Med. 2016 Nov 29;4:2050312116681224
pubmed: 27928502
Ann Intern Med. 2018 Oct 2;169(7):467-473
pubmed: 30178033
PLoS One. 2013 Aug 30;8(8):e72860
pubmed: 24023651
Implement Sci. 2010 Sep 20;5:69
pubmed: 20854677
Am J Kidney Dis. 2016 Oct;68(4):582-590
pubmed: 27257016
Lancet. 2011 Feb 12;377(9765):578-86
pubmed: 21295847
CMAJ Open. 2019 Sep 9;7(3):E568-E572
pubmed: 31501170
Prev Chronic Dis. 2017 Jul 20;14:E58
pubmed: 28727546
Lancet. 2019 Jun 22;393(10190):2493-2502
pubmed: 31076174
JAMA. 2017 Jan 10;317(2):165-182
pubmed: 28097354
Can J Diabetes. 2014 Aug;38(4):237-43
pubmed: 24986804
Contemp Clin Trials. 2017 Jan;52:20-26
pubmed: 27769897
Lancet Glob Health. 2018 Oct;6(10):e1077-e1086
pubmed: 30193830
Circulation. 2016 Aug 9;134(6):441-50
pubmed: 27502908
J Clin Hypertens (Greenwich). 2019 Jan;21(1):29-36
pubmed: 30474909
Lancet. 2017 Dec 16;390(10113):2627-2642
pubmed: 29029897

Auteurs

Ikechi G Okpechi (IG)

Division of Nephrology and Immunology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.
Division of Nephrology and Hypertension, University of Cape Town, Cape Town, South Africa.
Kidney and Hypertension Research Unit, University of Cape Town, Cape Town, South Africa.

Vinash Kumar Hariramani (VK)

Division of Nephrology and Immunology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.

Naima Sultana (N)

Division of Nephrology and Immunology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.

Anukul Ghimire (A)

Division of Nephrology and Immunology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.

Deenaz Zaidi (D)

Division of Nephrology and Immunology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.

Shezel Muneer (S)

Division of Nephrology and Immunology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.

Mohammed M Tinwala (MM)

Division of Nephrology and Immunology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.

Feng Ye (F)

Division of Nephrology and Immunology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.

Megan Sebastianski (M)

Knowledge Translation Platform, Alberta SPOR SUPPORT Unit Department of Pediatrics, University of Alberta, Edmonton, Canada.

Abdullah Abdulrahman (A)

Division of Nephrology and Immunology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.

Branko Braam (B)

Division of Nephrology and Immunology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.

Kailash Jindal (K)

Division of Nephrology and Immunology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.

Maryam Khan (M)

Division of Nephrology and Immunology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.

Scott Klarenbach (S)

Division of Nephrology and Immunology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.

Soroush Shojai (S)

Division of Nephrology and Immunology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.

Stephanie Thompson (S)

Division of Nephrology and Immunology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.

Aminu K Bello (AK)

Division of Nephrology and Immunology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH